市場調查報告書

蛋白質A樹脂的全球市場 - 各來源、成分矩陣、用途、使用者分析與產業的規模,佔有率及成長預測:到2030年

Protein A Resin Market Research Report: By Source, Matrix, Application, End User and Industry Size, Share, Trends and Forecast to 2030

出版商 Prescient & Strategic Intelligence Private Limited 商品編碼 930704
出版日期 內容資訊 英文 184 Pages
商品交期: 2-3個工作天內
價格
蛋白質A樹脂的全球市場 - 各來源、成分矩陣、用途、使用者分析與產業的規模,佔有率及成長預測:到2030年 Protein A Resin Market Research Report: By Source, Matrix, Application, End User and Industry Size, Share, Trends and Forecast to 2030
出版日期: 2020年01月01日內容資訊: 英文 184 Pages
簡介

蛋白質A樹脂市場主要推動要素,是人口高齡化,慢性疾病擴大,蛋白質研究的資金提供,對應各種條件的治療方法需求的必要性等。其市場收益從2019年的4億8640萬美元,預計在2019-2030年的分析期間以7.0%的年成長率擴大,2030年劇增到10億207萬美元。蛋白質A樹脂在免疫沉澱和層析法等純化過程用作分離介質的物質,分離酵素系生物混合物和抗原抗體,受體、核酸互動。

本報告以蛋白質A樹脂的全球市場為焦點,提供在2019-2030年的分析期間,各來源,成分矩陣,用途,使用者,地區的交易規模估算,更提供參與企業間的競爭情形等最新的調查資訊。

第1章 背景調查

  • 調查目的
  • 市場定義
  • 調查範圍
    • 各來源市場區隔
    • 各成分矩陣市場區隔
    • 各用途市場區分
    • 各使用者市場區隔
    • 各地區市場區分
    • 分析對象期間
    • 市場資料的記載單位
  • 主要相關利益者

第2章 調查方法

  • 二次調查
  • 一次調查
    • 一次資訊提供者的明細
  • 市場規模的估算
  • 三角法資料評估
  • 調查的前提

第3章 摘要整理

第4章 簡介

  • 市場區隔定義
    • 各來源
    • 各成分矩陣
    • 各用途
    • 各使用者
  • 市場動態
    • 潮流
    • 推動要素
    • 阻礙因素
    • 發展機會
  • 波特的五力分析

第5章 全球市場的規模與預測

  • 各來源
  • 各成分矩陣
  • 各用途
  • 各使用者
  • 各地區

第6章 北美的市場規模與預測

  • 各來源
  • 各成分矩陣
  • 各用途
  • 各使用者
  • 各國
    • 美國
    • 加拿大

第7章 歐洲的市場規模與預測

  • 各來源
  • 各成分矩陣
  • 各用途
  • 各使用者
  • 各國
    • 德國
    • 法國
    • 義大利
    • 英國
    • 西班牙

第8章 亞太地區的市場規模與預測

  • 各來源
  • 各成分矩陣
  • 各用途
  • 各使用者
  • 各國
    • 日本
    • 中國
    • 印度

第9章 中南美的市場規模與預測

  • 各來源
  • 各成分矩陣
  • 各用途
  • 各使用者
  • 各國

第10章 中東、非洲市場規模與預測

  • 各來源
  • 各成分矩陣
  • 各用途
  • 各使用者
  • 各國

第11章 競爭環境

  • 各企業佔有率分析
  • 主要加入企業的產品基準
  • 主要企業的對策展開
    • 事業收購
    • 企業合作
    • 其他的發展

第12章 企業簡介(產業概要,提供品目、服務,主要收支摘要等)

  • Bio-Works Technologies AB
  • Amikozen Co. Ltd.
  • Bio-Rad Laboratories Inc.
  • Expedeon AG
  • Thermo Fisher Scientific Inc.
  • GenScript Biotech Corporation
  • Merck KGaA
  • Tosoh Corporation
  • Repligen Corporation
  • Novasep Holding SAS
  • Purolite Corporation
  • Kaneka Corporation
  • General Electric Company

第13章 附錄

  • 簡稱
  • 出處和參考資料
  • 相關報告
目錄

The major protein A resin market drivers are the increasing geriatric population, prevalence of chronic diseases, funding for protein research, and need to meet the need for therapies for various conditions. The market revenue is projected to surge to $1,020.7 million by 2030, from $486.4 million in 2019, at a 7.0% CAGR during the forecast period (2019-2030). Protein A resin is used as a separation medium during purification processes, such immunoprecipitation and chromatography. It separates biochemical mixtures based on the enzyme-substrate, antigen-antibody, and receptor-nucleic acid interactions.

Based on source, the protein A resin market is bifurcated into natural and recombinant, of which the recombinant bifurcation would display the higher CAGR, of 7.5%, during the forecast period. This is because recombinant protein A resins are heavily used during the production of monoclonal antibodies (mAb). Earlier, pharmaceutical companies did not pursue mAbs, owing to their stability, size, degradation rate, and delivery limitations. But, with increasing funding and focus of private and public institutions on protein-based research, the development of mAbs is picking up pace.

Across the world, the need for effective treatments for metabolic diseases, cardiovascular diseases, infectious diseases, and cancer is highly unmet. This is promoting the development of monoclonal antibodies, as they can function similar to the mediators involved in pathological processes. Additionally, mAbs and other therapeutic proteins are less toxic, highly effective and potent, safe, tolerable, selective, and chemically and biologically diverse, and they also do not accumulate much on tissues. Therefore, with the increase in the research and development (R&D) for mAbs, the usage of protein A resin would rise.

The application segment of the market also has two bifurcations - antibody purification and immunoprecipitation - of which antibody purification held the larger share in 2019 and it would also grow faster during the forecast period, at a 7.2% CAGR. Similarly, of the two bifurcations within the end user segment - academic institutes & research laboratories and biotechnology & pharmaceutical industries - the latter dominated the protein A resin market in 2019, with a 91.6% value share. This end user consumes the biomaterial in huge amounts to produce mAbs.

One of the primary reasons behind the rising demand for monoclonal antibodies is the increasing incidence of chronic diseases. mAbs display a suitable pharmacokinetic profile, their solubility can be customized, and they also have a lesser chance of inducing an immune response, which is essential for the treatment to work. The diseases caused by hepatitis C virus (HCV), human immunodeficiency virus (HIV), and human papillomavirus (HPV) are increasing in prevalence, due to the low accessibility of healthcare in developing nations.

As per the Joint United Nations Program on HIV and AIDS (UNAIDS), 36.9 million had HIV in 2017. Similarly, as per the data jointly published by the American Stroke Association (ASA) and American Heart Association (AHA), heart diseases killed 836,546 people in the U.S. in 2018. Further, the World Health Organization (WHO) estimates the number of cancer cases, expected to be diagnosed in 2030, at 21.4 million. Thus, the rising prevalence of such diseases will lead to a surging demand for mAbs, thereby driving the protein A resin market advance.

Geographically, North America led the market in 2019, with a share of 37.4%, owing to the increasing requirement for protein therapeutics for chronic diseases and rising number of biopharmaceuticals with the Food and Drug Administration's approval. During the forecast period, Asia-Pacific (APAC) would observe the fastest progress in the protein A resin market during the forecast period, at a 7.8% CAGR. This would be because of the rising usage of such biomaterial in drug research, technological advancements, growing pharmaceutical sector, and surging demand for vaccines and other therapeutics.

Therefore, with the increasing R&D for drugs and disease treatment, especially for monoclonal antibodies, the consumption of protein A resin would also escalate.

TABLE OF CONTENTS

Chapter 1. Research Background

  • 1.1 Research Objectives
  • 1.2 Market Definition
  • 1.3 Research Scope
    • 1.3.1 Market Segmentation by Source
    • 1.3.2 Market Segmentation by Matrix
    • 1.3.3 Market Segmentation by Application
    • 1.3.4 Market Segmentation by End User
    • 1.3.5 Market Segmentation by Geography
    • 1.3.6 Analysis Period
    • 1.3.7 Market Data Reporting Unit
  • 1.4 Key Stakeholders

Chapter 2. Research Methodology

  • 2.1 Secondary Research
  • 2.2 Primary Research
    • 2.2.1 Breakdown of Primary Research Respondents
      • 2.2.1.1 By region
      • 2.2.1.2 By industry participant
      • 2.2.1.3 By company type
  • 2.3 Market Size Estimation
  • 2.4 Data Triangulation
  • 2.5 Assumptions for the Study

Chapter 3. Executive Summary

Chapter 4. Introduction

  • 4.1 Definition of Market Segments
    • 4.1.1 By Source
      • 4.1.1.1 Recombinant
      • 4.1.1.2 Natural
    • 4.1.2 By Matrix
      • 4.1.2.1 Agarose-based protein A
      • 4.1.2.2 Glass or silica-based protein A
      • 4.1.2.3 Organic polymer-based protein A
      • 4.1.2.4 Others
    • 4.1.3 By Application
      • 4.1.3.1 Antibody purification
      • 4.1.3.2 Immunoprecipitation
    • 4.1.4 By End User
      • 4.1.4.1 Biotechnology and pharmaceutical industries
      • 4.1.4.2 Academic institutes and research laboratories
  • 4.2 Market Dynamics
    • 4.2.1 Trends
      • 4.2.1.1 Increasing number of collaborations and agreements
      • 4.2.1.2 Evolution of the market with product launches
    • 4.2.2 Drivers
      • 4.2.2.1 Increasing research activities to address unmet medical needs in various therapeutic areas
      • 4.2.2.2 Surging burden of chronic diseases
      • 4.2.2.3 Rising investment and funding for protein-based research
      • 4.2.2.4 Growing geriatric population
      • 4.2.2.5 Impact analysis of drivers on market forecast
    • 4.2.3 Restraints
      • 4.2.3.1 Lack of updated regulatory standards
      • 4.2.3.2 Contamination issues during protein A synthesis and high capital requirements for drug development
      • 4.2.3.3 Complex nature of protein A chromatography process
      • 4.2.3.4 Impact analysis of restraints on market forecast
    • 4.2.4 Opportunities
      • 4.2.4.1 Emerging markets in the APAC region
  • 4.3 Porter's Five Forces Analysis

Chapter 5. Global Market Size and Forecast

  • 5.1 By Source
  • 5.2 By Matrix
  • 5.3 By Application
  • 5.4 By End User
  • 5.5 By Region

Chapter 6. North America Market Size and Forecast

  • 6.1 By Source
  • 6.2 By Matrix
  • 6.3 By Application
  • 6.4 By End User
  • 6.5 By Country
    • 6.5.1 U.S. Market Size and Forecast
      • 6.5.1.1 By source
      • 6.5.1.2 By matrix
      • 6.5.1.3 By application
      • 6.5.1.4 By end user
    • 6.5.2 Canada Market Size and Forecast
      • 6.5.2.1 By source
      • 6.5.2.2 By matrix
      • 6.5.2.3 By application
      • 6.5.2.4 By end user

Chapter 7. Europe Market Size and Forecast

  • 7.1 By Source
  • 7.2 By Matrix
  • 7.3 By Application
  • 7.4 By End User
  • 7.5 By Country
    • 7.5.1 Germany Market Size and Forecast
      • 7.5.1.1 By source
      • 7.5.1.2 By matrix
      • 7.5.1.3 By application
      • 7.5.1.4 By end user
    • 7.5.2 France Market Size and Forecast
      • 7.5.2.1 By source
      • 7.5.2.2 By matrix
      • 7.5.2.3 By application
      • 7.5.2.4 By end user
    • 7.5.3 Italy Market Size and Forecast
      • 7.5.3.1 By source
      • 7.5.3.2 By matrix
      • 7.5.3.3 By application
      • 7.5.3.4 By end user
    • 7.5.4 U.K. Market Size and Forecast
      • 7.5.4.1 By source
      • 7.5.4.2 By matrix
      • 7.5.4.3 By application
      • 7.5.4.4 By end user
    • 7.5.5 Spain Market Size and Forecast
      • 7.5.5.1 By source
      • 7.5.5.2 By matrix
      • 7.5.5.3 By application
      • 7.5.5.4 By end user

Chapter 8. APAC Market Size and Forecast

  • 8.1 By Source
  • 8.2 By Matrix
  • 8.3 By Application
  • 8.4 By End User
  • 8.5 By Country
    • 8.5.1 Japan Market Size and Forecast
      • 8.5.1.1 By source
      • 8.5.1.2 By matrix
      • 8.5.1.3 By application
      • 8.5.1.4 By end user
    • 8.5.2 China Market Size and Forecast
      • 8.5.2.1 By source
      • 8.5.2.2 By matrix
      • 8.5.2.3 By application
      • 8.5.2.4 By end user
    • 8.5.3 India Market Size and Forecast
      • 8.5.3.1 By source
      • 8.5.3.2 By matrix
      • 8.5.3.3 By application
      • 8.5.3.4 By end user

Chapter 9. LATAM Market Size and Forecast

  • 9.1 By Source
  • 9.2 By Matrix
  • 9.3 By Application
  • 9.4 By End User
  • 9.5 By Country

Chapter 10. MEA Market Size and Forecast

  • 10.1 By Source
  • 10.2 By Matrix
  • 10.3 By Application
  • 10.4 By End User
  • 10.5 By Country

Chapter 11. Competitive Landscape

  • 11.1 Company Share Analysis
  • 11.2 Product Benchmarking of Key Players
  • 11.3 Strategic Developments of Key Players
    • 11.3.1 Acquisitions
    • 11.3.2 Collaboration
    • 11.3.3 Other Developments

Chapter 12. Company Profiles

  • 12.1 Bio-Works Technologies AB
    • 12.1.1 Business Overview
    • 12.1.2 Product and Service Offerings
    • 12.1.3 Key Financial Summary
  • 12.2 Amikozen Co. Ltd.
    • 12.2.1 Business Overview
    • 12.2.2 Product and Service Offerings
  • 12.3 Bio-Rad Laboratories Inc.
    • 12.3.1 Business Overview
    • 12.3.2 Product and Service Offerings
    • 12.3.3 Key Financial Summary
  • 12.4 Expedeon AG
    • 12.4.1 Business Overview
    • 12.4.2 Product and Service Offerings
    • 12.4.3 Key Financial Summary
  • 12.5 Thermo Fisher Scientific Inc.
    • 12.5.1 Business Overview
    • 12.5.2 Product and Service Offerings
    • 12.5.3 Key Financial Summary
  • 12.6 GenScript Biotech Corporation
    • 12.6.1 Business Overview
    • 12.6.2 Product and Service Offerings
    • 12.6.3 Key Financial Summary
  • 12.7 Merck KGaA
    • 12.7.1 Business Overview
    • 12.7.2 Product and Service Offerings
    • 12.7.3 Key Financial Summary
  • 12.8 Tosoh Corporation
    • 12.8.1 Business Overview
    • 12.8.2 Product and Service Offerings
    • 12.8.3 Key Financial Summary
  • 12.9 Repligen Corporation
    • 12.9.1 Business Overview
    • 12.9.2 Product and Service Offerings
    • 12.9.3 Key Financial Summary
  • 12.10 Novasep Holding SAS
    • 12.10.1 Business Overview
    • 12.10.2 Product and Service Offerings
  • 12.11 Purolite Corporation
    • 12.11.1 Business Overview
    • 12.11.2 Product and Service Offerings
  • 12.12 Kaneka Corporation
    • 12.12.1 Business Overview
    • 12.12.2 Product and Service Offerings
    • 12.12.3 Key Financial Summary
  • 12.13 General Electric Company
    • 12.13.1 Business Overview
    • 12.13.2 Product and Service Offerings
    • 12.13.3 Key Financial Summary

Chapter 13. Appendix

  • 13.1 Abbreviations
  • 13.2 Sources and References
  • 13.3 Related Reports

List of Tables

  • TABLE 1 ANALYSIS PERIOD OF THE STUDY
  • TABLE 2 NUMBER OF DEATHS DUE TO VARIOUS DISEASES WORLDWIDE
  • TABLE 3 DRIVERS FOR THE MARKET: IMPACT ANALYSIS
  • TABLE 4 RESTRAINTS FOR THE MARKET: IMPACT ANALYSIS
  • TABLE 5 GLOBAL PROTEIN A RESIN MARKET, BY SOURCE, $M (2014-2019)
  • TABLE 6 GLOBAL PROTEIN A RESIN MARKET, BY SOURCE, $M (2020-2030)
  • TABLE 7 GLOBAL PROTEIN A RESIN MARKET, BY MATRIX, $M (2014-2019)
  • TABLE 8 GLOBAL PROTEIN A RESIN MARKET, BY MATRIX, $M (2020-2030)
  • TABLE 9 GLOBAL PROTEIN A RESIN MARKET, BY APPLICATION, $M (2014-2019)
  • TABLE 10 GLOBAL PROTEIN A RESIN MARKET, BY APPLICATION, $M (2020-2030)
  • TABLE 11 GLOBAL PROTEIN A RESIN MARKET, BY END USER, $M (2014-2019)
  • TABLE 12 GLOBAL PROTEIN A RESIN MARKET, BY END USER, $M (2020-2030)
  • TABLE 13 GLOBAL PROTEIN A RESIN MARKET, BY REGION, $M (2014-2019)
  • TABLE 14 GLOBAL PROTEIN A RESIN MARKET, BY REGION, $M (2020-2030)
  • TABLE 15 NORTH AMERICA PROTEIN A RESIN MARKET, BY SOURCE, $M (2014-2019)
  • TABLE 16 NORTH AMERICA PROTEIN A RESIN MARKET, BY SOURCE, $M (2020-2030)
  • TABLE 17 NORTH AMERICA PROTEIN A RESIN MARKET, BY MATRIX, $M (2014-2019)
  • TABLE 18 NORTH AMERICA PROTEIN A RESIN MARKET, BY MATRIX, $M (2020-2030)
  • TABLE 19 NORTH AMERICA PROTEIN A RESIN MARKET, BY APPLICATION, $M (2014-2019)
  • TABLE 20 NORTH AMERICA PROTEIN A RESIN MARKET, BY APPLICATION, $M (2020-2030)
  • TABLE 21 NORTH AMERICA PROTEIN A RESIN MARKET, BY END USER, $M (2014-2019)
  • TABLE 22 NORTH AMERICA PROTEIN A RESIN MARKET, BY END USER, $M (2020-2030)
  • TABLE 23 NORTH AMERICA PROTEIN A RESIN MARKET, BY COUNTRY, $M (2014-2019)
  • TABLE 24 NORTH AMERICA PROTEIN A RESIN MARKET, BY COUNTRY, $M (2020-2030)
  • TABLE 25 U.S. PROTEIN A RESIN MARKET, BY SOURCE, $M (2014-2019)
  • TABLE 26 U.S. PROTEIN A RESIN MARKET, BY SOURCE, $M (2020-2030)
  • TABLE 27 U.S. PROTEIN A RESIN MARKET, BY MATRIX, $M (2014-2019)
  • TABLE 28 U.S. PROTEIN A RESIN MARKET, BY MATRIX, $M (2020-2030)
  • TABLE 29 U.S. PROTEIN A RESIN MARKET, BY APPLICATION, $M (2014-2019)
  • TABLE 30 U.S. PROTEIN A RESIN MARKET, BY APPLICATION, $M (2020-2030)
  • TABLE 31 U.S. PROTEIN A RESIN MARKET, BY END USER, $M (2014-2019)
  • TABLE 32 U.S. PROTEIN A RESIN MARKET, BY END USER, $M (2020-2030)
  • TABLE 33 CANADA PROTEIN A RESIN MARKET, BY SOURCE, $M (2014-2019)
  • TABLE 34 CANADA PROTEIN A RESIN MARKET, BY SOURCE, $M (2020-2030)
  • TABLE 35 CANADA PROTEIN A RESIN MARKET, BY MATRIX, $M (2014-2019)
  • TABLE 36 CANADA PROTEIN A RESIN MARKET, BY MATRIX, $M (2020-2030)
  • TABLE 37 CANADA PROTEIN A RESIN MARKET, BY APPLICATION, $M (2014-2019)
  • TABLE 38 CANADA PROTEIN A RESIN MARKET, BY APPLICATION, $M (2020-2030)
  • TABLE 39 CANADA PROTEIN A RESIN MARKET, BY END USER, $M (2014-2019)
  • TABLE 40 CANADA PROTEIN A RESIN MARKET, BY END USER, $M (2020-2030)
  • TABLE 41 EUROPE PROTEIN A RESIN MARKET, BY SOURCE, $M (2014-2019)
  • TABLE 42 EUROPE PROTEIN A RESIN MARKET, BY SOURCE, $M (2020-2030)
  • TABLE 43 EUROPE PROTEIN A RESIN MARKET, BY MATRIX, $M (2014-2019)
  • TABLE 44 EUROPE PROTEIN A RESIN MARKET, BY MATRIX, $M (2020-2030)
  • TABLE 45 EUROPE PROTEIN A RESIN MARKET, BY APPLICATION, $M (2014-2019)
  • TABLE 46 EUROPE PROTEIN A RESIN MARKET, BY APPLICATION, $M (2020-2030)
  • TABLE 47 EUROPE PROTEIN A RESIN MARKET, BY END USER, $M (2014-2019)
  • TABLE 48 EUROPE PROTEIN A RESIN MARKET, BY END USER, $M (2020-2030)
  • TABLE 49 EUROPE PROTEIN A RESIN MARKET, BY COUNTRY, $M (2014-2019)
  • TABLE 50 EUROPE PROTEIN A RESIN MARKET, BY COUNTRY, $M (2020-2030)
  • TABLE 51 GERMANY PROTEIN A RESIN MARKET, BY SOURCE, $M (2014-2019)
  • TABLE 52 GERMANY PROTEIN A RESIN MARKET, BY SOURCE, $M (2020-2030)
  • TABLE 53 GERMANY PROTEIN A RESIN MARKET, BY MATRIX, $M (2014-2019)
  • TABLE 54 GERMANY PROTEIN A RESIN MARKET, BY MATRIX, $M (2020-2030)
  • TABLE 55 GERMANY PROTEIN A RESIN MARKET, BY APPLICATION, $M (2014-2019)
  • TABLE 56 GERMANY PROTEIN A RESIN MARKET, BY APPLICATION, $M (2020-2030)
  • TABLE 57 GERMANY PROTEIN A RESIN MARKET, BY END USER, $M (2014-2019)
  • TABLE 58 GERMANY PROTEIN A RESIN MARKET, BY END USER, $M (2020-2030)
  • TABLE 59 FRANCE PROTEIN A RESIN MARKET, BY SOURCE, $M (2014-2019)
  • TABLE 60 FRANCE PROTEIN A RESIN MARKET, BY SOURCE, $M (2020-2030)
  • TABLE 61 FRANCE PROTEIN A RESIN MARKET, BY MATRIX, $M (2014-2019)
  • TABLE 62 FRANCE PROTEIN A RESIN MARKET, BY MATRIX, $M (2020-2030)
  • TABLE 63 FRANCE PROTEIN A RESIN MARKET, BY APPLICATION, $M (2014-2019)
  • TABLE 64 FRANCE PROTEIN A RESIN MARKET, BY APPLICATION, $M (2020-2030)
  • TABLE 65 FRANCE PROTEIN A RESIN MARKET, BY END USER, $M (2014-2019)
  • TABLE 66 FRANCE PROTEIN A RESIN MARKET, BY END USER, $M (2020-2030)
  • TABLE 67 ITALY PROTEIN A RESIN MARKET, BY SOURCE, $M (2014-2019)
  • TABLE 68 ITALY PROTEIN A RESIN MARKET, BY SOURCE, $M (2020-2030)
  • TABLE 69 ITALY PROTEIN A RESIN MARKET, BY MATRIX, $M (2014-2019)
  • TABLE 70 ITALY PROTEIN A RESIN MARKET, BY MATRIX, $M (2020-2030)
  • TABLE 71 ITALY PROTEIN A RESIN MARKET, BY APPLICATION, $M (2014-2019)
  • TABLE 72 ITALY PROTEIN A RESIN MARKET, BY APPLICATION, $M (2020-2030)
  • TABLE 73 ITALY PROTEIN A RESIN MARKET, BY END USER, $M (2014-2019)
  • TABLE 74 ITALY PROTEIN A RESIN MARKET, BY END USER, $M (2020-2030)
  • TABLE 75 U.K. PROTEIN A RESIN MARKET, BY SOURCE, $M (2014-2019)
  • TABLE 76 U.K. PROTEIN A RESIN MARKET, BY SOURCE, $M (2020-2030)
  • TABLE 77 U.K. PROTEIN A RESIN MARKET, BY MATRIX, $M (2014-2019)
  • TABLE 78 U.K. PROTEIN A RESIN MARKET, BY MATRIX, $M (2020-2030)
  • TABLE 79 U.K. PROTEIN A RESIN MARKET, BY APPLICATION, $M (2014-2019)
  • TABLE 80 U.K. PROTEIN A RESIN MARKET, BY APPLICATION, $M (2020-2030)
  • TABLE 81 U.K. PROTEIN A RESIN MARKET, BY END USER, $M (2014-2019)
  • TABLE 82 U.K. PROTEIN A RESIN MARKET, BY END USER, $M (2020-2030)
  • TABLE 83 SPAIN PROTEIN A RESIN MARKET, BY SOURCE, $M (2014-2019)
  • TABLE 84 SPAIN PROTEIN A RESIN MARKET, BY SOURCE, $M (2020-2030)
  • TABLE 85 SPAIN PROTEIN A RESIN MARKET, BY MATRIX, $M (2014-2019)
  • TABLE 86 SPAIN PROTEIN A RESIN MARKET, BY MATRIX, $M (2020-2030)
  • TABLE 87 SPAIN PROTEIN A RESIN MARKET, BY APPLICATION, $M (2014-2019)
  • TABLE 88 SPAIN PROTEIN A RESIN MARKET, BY APPLICATION, $M (2020-2030)
  • TABLE 89 SPAIN PROTEIN A RESIN MARKET, BY END USER, $M (2014-2019)
  • TABLE 90 SPAIN PROTEIN A RESIN MARKET, BY END USER, $M (2020-2030)
  • TABLE 91 APAC PROTEIN A RESIN MARKET, BY SOURCE, $M (2014-2019)
  • TABLE 92 APAC PROTEIN A RESIN MARKET, BY SOURCE, $M (2020-2030)
  • TABLE 93 APAC PROTEIN A RESIN MARKET, BY MATRIX, $M (2014-2019)
  • TABLE 94 APAC PROTEIN A RESIN MARKET, BY MATRIX, $M (2020-2030)
  • TABLE 95 APAC PROTEIN A RESIN MARKET, BY APPLICATION, $M (2014-2019)
  • TABLE 96 APAC PROTEIN A RESIN MARKET, BY APPLICATION, $M (2020-2030)
  • TABLE 97 APAC PROTEIN A RESIN MARKET, BY END USER, $M (2014-2019)
  • TABLE 98 APAC PROTEIN A RESIN MARKET, BY END USER, $M (2020-2030)
  • TABLE 99 APAC PROTEIN A RESIN MARKET, BY COUNTRY, $M (2014-2019)
  • TABLE 100 APAC PROTEIN A RESIN MARKET, BY COUNTRY, $M (2020-2030)
  • TABLE 101 JAPAN PROTEIN A RESIN MARKET, BY SOURCE, $M (2014-2019)
  • TABLE 102 JAPAN PROTEIN A RESIN MARKET, BY SOURCE, $M (2020-2030)
  • TABLE 103 JAPAN PROTEIN A RESIN MARKET, BY MATRIX, $M (2014-2019)
  • TABLE 104 JAPAN PROTEIN A RESIN MARKET, BY MATRIX, $M (2020-2030)
  • TABLE 105 JAPAN PROTEIN A RESIN MARKET, BY APPLICATION, $M (2014-2019)
  • TABLE 106 JAPAN PROTEIN A RESIN MARKET, BY APPLICATION, $M (2020-2030)
  • TABLE 107 JAPAN PROTEIN A RESIN MARKET, BY END USER, $M (2014-2019)
  • TABLE 108 JAPAN PROTEIN A RESIN MARKET, BY END USER, $M (2020-2030)
  • TABLE 109 CHINA PROTEIN A RESIN MARKET, BY SOURCE, $M (2014-2019)
  • TABLE 110 CHINA PROTEIN A RESIN MARKET, BY SOURCE, $M (2020-2030)
  • TABLE 111 CHINA PROTEIN A RESIN MARKET, BY MATRIX, $M (2014-2019)
  • TABLE 112 CHINA PROTEIN A RESIN MARKET, BY MATRIX, $M (2020-2030)
  • TABLE 113 CHINA PROTEIN A RESIN MARKET, BY APPLICATION, $M (2014-2019)
  • TABLE 114 CHINA PROTEIN A RESIN MARKET, BY APPLICATION, $M (2020-2030)
  • TABLE 115 CHINA PROTEIN A RESIN MARKET, BY END USER, $M (2014-2019)
  • TABLE 116 CHINA PROTEIN A RESIN MARKET, BY END USER, $M (2020-2030)
  • TABLE 117 INDIA PROTEIN A RESIN MARKET, BY SOURCE, $M (2014-2019)
  • TABLE 118 INDIA PROTEIN A RESIN MARKET, BY SOURCE, $M (2020-2030)
  • TABLE 119 INDIA PROTEIN A RESIN MARKET, BY MATRIX, $M (2014-2019)
  • TABLE 120 INDIA PROTEIN A RESIN MARKET, BY MATRIX, $M (2020-2030)
  • TABLE 121 INDIA PROTEIN A RESIN MARKET, BY APPLICATION, $M (2014-2019)
  • TABLE 122 INDIA PROTEIN A RESIN MARKET, BY APPLICATION, $M (2020-2030)
  • TABLE 123 INDIA PROTEIN A RESIN MARKET, BY END USER, $M (2014-2019)
  • TABLE 124 INDIA PROTEIN A RESIN MARKET, BY END USER, $M (2020-2030)
  • TABLE 125 LATAM PROTEIN A RESIN MARKET, BY SOURCE, $M (2014-2019)
  • TABLE 126 LATAM PROTEIN A RESIN MARKET, BY SOURCE, $M (2020-2030)
  • TABLE 127 LATAM PROTEIN A RESIN MARKET, BY MATRIX, $M (2014-2019)
  • TABLE 128 LATAM PROTEIN A RESIN MARKET, BY MATRIX, $M (2020-2030)
  • TABLE 129 LATAM PROTEIN A RESIN MARKET, BY APPLICATION, $M (2014-2019)
  • TABLE 130 LATAM PROTEIN A RESIN MARKET, BY APPLICATION, $M (2020-2030)
  • TABLE 131 LATAM PROTEIN A RESIN MARKET, BY END USER, $M (2014-2019)
  • TABLE 132 LATAM PROTEIN A RESIN MARKET, BY END USER, $M (2020-2030)
  • TABLE 133 LATAM PROTEIN A RESIN MARKET, BY COUNTRY, $M (2014-2019)
  • TABLE 134 LATAM PROTEIN A RESIN MARKET, BY COUNTRY, $M (2020-2030)
  • TABLE 135 MEA PROTEIN A RESIN MARKET, BY SOURCE, $M (2014-2019)
  • TABLE 136 MEA PROTEIN A RESIN MARKET, BY SOURCE, $M (2020-2030)
  • TABLE 137 MEA PROTEIN A RESIN MARKET, BY MATRIX, $M (2014-2019)
  • TABLE 138 MEA PROTEIN A RESIN MARKET, BY MATRIX, $M (2020-2030)
  • TABLE 139 MEA PROTEIN A RESIN MARKET, BY APPLICATION, $M (2014-2019)
  • TABLE 140 MEA PROTEIN A RESIN MARKET, BY APPLICATION, $M (2020-2030)
  • TABLE 141 MEA PROTEIN A RESIN MARKET, BY END USER, $M (2014-2019)
  • TABLE 142 MEA PROTEIN A RESIN MARKET, BY END USER, $M (2020-2030)
  • TABLE 143 MEA PROTEIN A RESIN MARKET, BY COUNTRY, $M (2014-2019)
  • TABLE 144 MEA PROTEIN A RESIN MARKET, BY COUNTRY, $M (2020-2030)
  • TABLE 145 BIO-WORKS TECHNOLOGIES AB - AT A GLANCE
  • TABLE 146 BIO-WORKS TECHNOLOGIES AB - KEY FINANCIAL SUMMARY
  • TABLE 147 AMIKOZEN CO. LTD. - AT A GLANCE
  • TABLE 148 BIO-RAD LABORATORIES INC - AT A GLANCE
  • TABLE 149 BIO-RAD LABORATORIES INC - KEY FINANCIAL SUMMARY
  • TABLE 150 EXPEDEON AG - AT A GLANCE
  • TABLE 151 EXPEDEON AG - KEY FINANCIAL SUMMARY
  • TABLE 152 THERMO FISHER SCIENTIFIC INC. - AT A GLANCE
  • TABLE 153 THERMO FISHER SCIENTIFIC INC. - KEY FINANCIAL SUMMARY
  • TABLE 154 GENSCRIPT BIOTECH CORPORATION - AT A GLANCE
  • TABLE 155 GENSCRIPT BIOTECH CORPORATION - KEY FINANCIAL SUMMARY
  • TABLE 156 MERCK KGAA - AT A GLANCE
  • TABLE 157 MERCK KGAA - KEY FINANCIAL SUMMARY
  • TABLE 158 TOSOH CORPORATION - AT A GLANCE
  • TABLE 159 TOSOH CORPORATION - KEY FINANCIAL SUMMARY
  • TABLE 160 REPLIGEN CORPORATION - AT A GLANCE
  • TABLE 161 REPLIGEN CORPORATION - KEY FINANCIAL SUMMARY
  • TABLE 162 NOVASEP HOLDING SAS - AT A GLANCE
  • TABLE 163 PUROLITE CORPORATION - AT A GLANCE
  • TABLE 164 KANEKA CORPORATION - AT A GLANCE
  • TABLE 165 KANEKA CORPORATION - KEY FINANCIAL SUMMARY
  • TABLE 166 GENERAL ELECTRIC COMPANY - AT A GLANCE
  • TABLE 167 GENERAL ELECTRIC COMPANY - KEY FINANCIAL SUMMARY

List of Figures

  • FIG 1 RESEARCH SCOPE
  • FIG 2 RESEARCH METHODOLOGY
  • FIG 3 REGIONAL SPLIT OF PRIMARY AND SECONDARY RESEARCH
  • FIG 4 BREAKDOWN OF PRIMARY RESEARCH BY REGION
  • FIG 5 BREAKDOWN OF PRIMARY RESEARCH BY INDUSTRY PARTICIPANT
  • FIG 6 BREAKDOWN OF PRIMARY RESEARCH BY COMPANY TYPE
  • FIG 7 DATA TRIANGULATION APPROACH
  • FIG 8 GLOBAL PROTEIN A RESIN MARKET SUMMARY
  • FIG 9 PERCENTAGE SHARE OF ELDERLY PEOPLE IN TOTAL POPULATION
  • FIG 10 BARGAINING POWER OF BUYERS
  • FIG 11 BARGAINING POWER OF SUPPLIERS
  • FIG 12 INTENSITY OF RIVALRY
  • FIG 13 THREAT OF NEW ENTRANTS
  • FIG 14 THREAT OF SUBSTITUTES
  • FIG 15 SNAPSHOT OF GLOBAL PROTEIN A RESIN MARKET
  • FIG 16 GLOBAL PROTEIN A RESIN MARKET, BY SOURCE, $M (2014-2030)
  • FIG 17 GLOBAL PROTEIN A RESIN MARKET, BY MATRIX, $M (2014-2030)
  • FIG 18 GLOBAL PROTEIN A RESIN MARKET, BY APPLICATION, $M (2014-2030)
  • FIG 19 GLOBAL PROTEIN A RESIN MARKET, BY END USER, $M (2014-2030)
  • FIG 20 GLOBAL PROTEIN A RESIN MARKET, BY REGION, $M (2014-2030)
  • FIG 21 NORTH AMERICA PROTEIN A RESIN MARKET SNAPSHOT
  • FIG 22 NORTH AMERICA PROTEIN A RESIN MARKET, BY SOURCE, $M (2014-2030)
  • FIG 23 NORTH AMERICA PROTEIN A RESIN MARKET, BY MATRIX, $M (2014-2030)
  • FIG 24 NORTH AMERICA PROTEIN A RESIN MARKET, BY APPLICATION, $M (2014-2030)
  • FIG 25 NORTH AMERICA PROTEIN A RESIN MARKET, BY END USER, $M (2014-2030)
  • FIG 26 NORTH AMERICA PROTEIN A RESIN MARKET, BY COUNTRY, $M (2014-2030)
  • FIG 27 EUROPE PROTEIN A RESIN MARKET SNAPSHOT
  • FIG 28 EUROPE PROTEIN A RESIN MARKET, BY SOURCE, $M (2014-2030)
  • FIG 29 EUROPE PROTEIN A RESIN MARKET, BY MATRIX, $M (2014-2030)
  • FIG 30 EUROPE PROTEIN A RESIN MARKET, BY APPLICATION, $M (2014-2030)
  • FIG 31 EUROPE PROTEIN A RESIN MARKET, BY END USER, $M (2014-2030)
  • FIG 32 EUROPE PROTEIN A RESIN MARKET, BY COUNTRY, $M (2014-2030)
  • FIG 33 APAC PROTEIN A RESIN MARKET SNAPSHOT
  • FIG 34 APAC PROTEIN A RESIN MARKET, BY SOURCE, $M (2014-2030)
  • FIG 35 APAC PROTEIN A RESIN MARKET, BY MATRIX, $M (2014-2030)
  • FIG 36 APAC PROTEIN A RESIN MARKET, BY APPLICATION, $M (2014-2030)
  • FIG 37 APAC PROTEIN A RESIN MARKET, BY END USER, $M (2014-2030)
  • FIG 38 APAC PROTEIN A RESIN MARKET, BY COUNTRY, $M (2014-2030)
  • FIG 39 LATAM PROTEIN A RESIN MARKET SNAPSHOT
  • FIG 40 LATAM PROTEIN A RESIN MARKET, BY SOURCE, $M (2014-2030)
  • FIG 41 LATAM PROTEIN A RESIN MARKET, BY MATRIX, $M (2014-2030)
  • FIG 42 LATAM PROTEIN A RESIN MARKET, BY APPLICATION, $M (2014-2030)
  • FIG 43 LATAM PROTEIN A RESIN MARKET, BY END USER, $M (2014-2030)
  • FIG 44 LATAM PROTEIN A RESIN MARKET, BY COUNTRY, $M (2014-2030)
  • FIG 45 MEA PROTEIN A RESIN MARKET SNAPSHOT
  • FIG 46 MEA PROTEIN A RESIN MARKET, BY SOURCE, $M (2014-2030)
  • FIG 47 MEA PROTEIN A RESIN MARKET, BY MATRIX, $M (2014-2030)
  • FIG 48 MEA PROTEIN A RESIN MARKET, BY APPLICATION, $M (2014-2030)
  • FIG 49 MEA PROTEIN A RESIN MARKET, BY END USER, $M (2014-2030)
  • FIG 50 MEA PROTEIN A RESIN MARKET, BY COUNTRY, $M (2014-2030)
  • FIG 51 PRODUCT BENCHMARKING OF KEY PLAYERS
  • FIG 52 BIO-WORKS TECHNOLOGIES AB - REVENUE SPLIT BY GEOGRAPHY (2018)
  • FIG 53 BIO-RAD LABORATORIES INC - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2018)
  • FIG 54 THERMO FISHER SCIENTIFIC INC. - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2018)
  • FIG 55 GENESCRIPT BIOTECH CORPORATION - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2017)
  • FIG 56 MERCK KGAA - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2018)
  • FIG 57 TOSOH CORPORATION - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2019)
  • FIG 58 REPLIGEN CORPORATION - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2018)
  • FIG 59 KANEKA CORPORATION - REVENUE SPLIT BY SEGMENT (2018)
  • FIG 60 GENERAL ELECTRIC COMPANY - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2018)